These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
875 related articles for article (PubMed ID: 19118020)
1. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020 [TBL] [Abstract][Full Text] [Related]
2. Molecular control of lymphatic metastasis. Achen MG; Stacker SA Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975 [TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417 [TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast. Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844 [TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
7. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer. Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542 [TBL] [Abstract][Full Text] [Related]
8. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318 [TBL] [Abstract][Full Text] [Related]
9. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer]. Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672 [TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade. Spinella F; Garrafa E; Di Castro V; Rosanò L; Nicotra MR; Caruso A; Natali PG; Bagnato A Cancer Res; 2009 Mar; 69(6):2669-76. PubMed ID: 19276384 [TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]. Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440 [TBL] [Abstract][Full Text] [Related]
12. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000 [TBL] [Abstract][Full Text] [Related]
13. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer. van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197 [TBL] [Abstract][Full Text] [Related]
14. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Zeng Y; Opeskin K; Goad J; Williams ED Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837 [TBL] [Abstract][Full Text] [Related]
17. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma. Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123 [TBL] [Abstract][Full Text] [Related]
19. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis. Tutunea-Fatan E; Majumder M; Xin X; Lala PK Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]